Navigation Links
Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview
Date:9/21/2010

NEW YORK, Sept. 21 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Biomarkers: Discovery Techniques and Applications – A Global Market Overview

http://www.reportlinker.com/p0296476/Biomarkers-Discovery-Techniques-and-Applications-–-A-Global-Market-Overview.html

`A more focused discovery process using proteins as biomarkers for various diseases has been in the development stage for quite some time now. The recent years have witnessed a more targeted approach in proteomics and biomarker discovery as against a broad exploration of the entire proteome. As a result, focus on sample preparation has gained in importance, with researchers devoting more time in simplifying sample through fractionation and enrichment. This has enabled in more informative data generated in biomarker discovery experiments.

Biomarker discovery technologies analyzed in this study include Bioinformatics, Genomics, Molecular Imaging, Proteomics and Other. The report is also analyses the global market for biomarker therapeutic areas comprising Cardiology, Neurology, Oncology and Other.The global market for markers is projected to reach US$26.5 billion by 2015, growing by a sturdy CAGR of 20.2% during the period 2007-2015.

The study reviews and analyses the worldwide market for Biomarkers. Rich statistical analysis is carried out for the global and the regional markets including the United States, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 10 independent countries across Europe – Germany, the United Kingdom, France, Italy, Spain, Sweden and Rest of Europe; Asia-Pacific –Japan, China, India, Australia and Rest of Asia-Pacific.

This 230 page global market report includes 92 rich data tables, supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value by geographic regions, biomarker discovery technologies and therapeutic areas. The report also profiles 52 key global players and 72 major players across the United States – 43; Europe – 19; Asia-Pacific – 4; and Rest of World – 2. The report also provides the listing of the companies engaged in research and development, equipment manufacturing, processing, supplies and distribution of biomarkers. The global list covers the addresses, contact numbers and the website addresses of 212 companies.

Table of Contents:1. GLOBAL MARKET PERSPECTIVE1.1 Introduction

1.2 Product Outline

1.2.1 Biomarkers

1.2.2 Biomarkers and Surrogate Endpoints

1.2.3 Nanobiotechnology's Biomarker Discovery for Personalized medicine

1.2.4 Biomarkers Research and Approval

1.2.5 Biomarker Discovery Technologies

1.2.5.1 Genomics

1.2.5.2 Proteomics

1.2.5.3 Bioinformatics

1.2.5.4 Molecular Imaging Technologies

1.2.5.5 Molecular Imaging Biomarkers for Cancer

1.2.5.6 Metabolomics

1.2.5.7 Nuclear Magnetic Resonance

1.2.6 Challenges in Discovering Biomarkers

1.3 Application Analysis

1.3.1 Biomarkers in Diagnostics

1.3.2 Biomarkers in Drug Discovery and Drug Development

1.3.2.1 Basic Drug Development Research

1.3.2.2 Later Drug Development

1.3.2.3 Clinical Trials

1.3.2.4 Future Uses

1.3.2.5 Concerns

1.3.3 Biomarkers in Ecotoxicology

1.3.4 Biomarkers in Exposure

1.3.5 Biomarkers in Therapeutics

1.3.5.1 Cardiology

Cardiac Biomarkers Used

Cardiac Biomarkers and Timing of Use

1.3.5.2 Oncology

1.3.5.3 Neurology

1.3.6 Biomarkers in Disease

Diabetes

Use of SELDI in Discovering Infectious Disease Biomarkers

1.3.7 MicroRNAs (miRNAs)

Functions of microRNAs

MicroRNAs as Biomarkers

MicroRNAs in Diseases

Malignancies

Multiple Sclerosis (MS)

Transplantation

1.4 Recent Biomarker Case Studies

1.4.1 CASE STUDY I – AAPS Workshop on Translational Biomarkers for Accelerating Drug Development

Purpose of the Study

Process of the Study

Regulatory Biomarkers

Results Ascertained/Problems Faced

1.4.2 CASE STUDY II – AMGEN

Purpose of the Study

Process Involved

Classes of Biomarkers

Selected Validated Biomarkers

Emerging Biomarkers: An Overview

1.4.3 CASE STUDY III – The Promise of Imaging Biomarkers-Thomson Reuters

Purpose of the Study

Introduction

Process

An Overview of Imaging Technologies in Use

R&D Applications of Imaging Biomarkers

Clinical Applications of Imaging Biomarkers

Future Vistas

Hurdles to be Crossed

Imaging Biomarkers' Application

What Lies in Store

1.4.4 CASE STUDY IV – Sperling and Johnson Alzheimer's Research & Therapy 2010

Purpose of the Study

Introduction

Process

Conclusions

1.4.5 CASE STUDY V – Shimadzu Scientific Instruments

Purpose of the Study

Introduction

Instance-1

Instance-2

Instance-3

1.5 Current Market Scenario

Phosphoproteomics Used in Identifying Potential Cancer Drug Development Biomarkers

Spinal Fluid Biomarkers Assist in Classifying Alzheimer's Disease Patients

Biomarker for Oral Cancer Discovered

Can Brain Injuries be detected by a Simple Blood Test?

Postmenopausal Cardiovascular Disease Biomarkers Discovered

Quantifying Urinary Biomarkers of Kidney Damage Using Multiplex Panels

Advancing Cancer Drug Development Using Biomarkers

Developing and Validating Imaging Biomarkers in Preclinical Drug Development

Ocular Disease Identifying Biomarkers in Ocular Fluid

Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology Enable in Drug Discovery and Translational Medicine

Role of Inflammation in Vascular Disease Shown by Biomarker Ratifies Ethnic Group Disease Progressions (USA)

Kidney Damage Biomarkers to Help in Speeding Drug Development

Parkinson's Disease and Need for Biomarkers

Goal of Effective and Personalized Cancer Medicine to be Realized by Biomarkers

Acute Coronary Syndrome and Diagnostic Biomarkers

Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics

A Metabonomic Approach to Identify Human Urinary Phenylacetylglutamine as an Innovative Marker of Interstitial Cystitis

Serum Biomarker for Autistic Spectrum Disorder

Prognostic Biomarker in Human Bladder Cancer

Breast Cancer Biomarker Discovery Using New Method

1.6 Major Global Players

Abbott Laboratories

ACE BioSciences A/S

Affibody AB

Affymetrix, Inc.

Agilent Technologies

Amgen

Applied NeuroSolutions

AstraZeneca plc

AVIVA Biosciences Corporation

Bayer AG

Beckman Coulter, Inc.

Becton, Dickinson and Company

BG Medicine, Inc.

Biacore International AB

Biocartis

Biomarker Pharmaceuticals, Inc.

Bio-Rad Laboratories

Boehringer Ingelheim

Bristol-Myers Squibb Company

Celera Corporation

Charles River Laboratories International, Inc.

Clarient, Inc.

Compugen Ltd.

Dako A/S

deCODE Genetics

Eli Lilly and Company

GE Healthcare

Gene Logic, Inc.

Genedata AG

GeneGo

Genentech, Inc.

Geron Corporation

GlaxoSmithKline

GVK Biosciences Private Ltd

HistoRx, Inc.

Merck & Co., Inc.

Millennium Pharmaceuticals, Inc.

Millipore Corporation

Monogram Biosciences, Inc.

Myriad Genetics, Inc.

Novartis AG

OSI Pharmaceuticals

PerkinElmer, Inc.

Pfizer, Inc.

Philips Healthcare

Roche Diagnostics Corporation

Sanofi-Aventis

Shimadzu Scientific Instruments, Inc.

Siemens Healthcare Diagnostics Inc.

Sigma-Aldrich Corporation

Takeda Pharmaceutical Company Limited

Thermo Fisher Scientific, Inc.

1.7 Key Business Trends

VisEn Medical Acquired by PerkinElmer

Hologic Acquires Sentinelle Medical

Thermo Fisher Scientific in Collaboration to Set Up New Biomarker Research Center in Tokyo

Axela Takes Over Xceed Molecular

Merck KGaA Acquires Millipore Corporation

Eli Lilly Acquires Alnara Pharmaceuticals

Fermentas International Inc Acquired by Thermo Fisher

Astellas Acquires OSI Pharmaceuticals

Critical Path's Protein Biomarker Panel for Drug Toxicity Studies Approved by Japanese Regulators

Roche Diagnostics, American College of Cardiology in Collaboration

Affymetrix Introduces Axiom™ Genome-Wide ASI Array

Abbott Acquires Facet Biotech

Biocartis and Royal Philips Electronics Form Agreement

Predictive Biosciences Acquires OncoDiagnostic Laboratory

QIAGEN N.V Completes Acquisition of SABiosciences

HandyLab, Inc Taken Over by Becton, Dickinson and Co

DxS Ltd Acquired by QIAGEN N.V

Thermo Fisher Acquires B-R-A-H-M-S

Bristol-Myers Squibb Acquires Medarex, Inc.

Agilent Completes Acquisition of Varian

PerkinElmer Completes Acquisition of Analytica of Branford, Inc

Tepnel Life Sciences Acquired by Gen-Probe

Roche Acquires Genentech

Affymetrix Acquires Panomics

Eli Lilly Acquires ImClone Systems

Affymetrix in Collaboration with Medical Prognosis Institute Develop Cancer

Treatment Products

September 2008

Bayer HealthCare AG Takes Over DIREVO Biotech AG

Charles River Takes Over MIR Preclinical Services

Lilly Completes SGX Acquisition

QIAGEN Takes Over Corbett Life Science

Thermo Fisher Scientific Completes Acquisition of Open Biosystems

GlaxoSmithKline Takes Over Sirtris Pharmaceuticals, Inc

BD Acquires Cytopeia

EUSA Pharma Acquires Cytogen Corporation

American Biological Technologies Acquired by Fujirebio Diagnostics

Celera, Merck in License Agreement for Cancer Targets

Abraxis BioScience Takes Over Shimoda Biotech and Platco Technologies

BG Medicine, ACS Biomarker B.V in an Agreement

Affymetrix Takes Over USB Corporation

1.8 Global Market Overview

1.8.1 Market Overview by Biomarker Discovery Technology

1.8.2 Market Overview by Biomarker Therapeutic Area

1.8.3 Biomarker Discovery Technology Market Overview by Global Region

1.8.3.1 Bioinformatics

1.8.3.2 Genomics

1.8.3.3 Molecular Imaging

1.8.3.4 Proteomics

1.8.3.5 Other Biomarker Discovery Technologies

1.8.4 Biomarker Therapeutic Area Market Overview by Global Region

1.8.4.1 Cardiology

1.8.4.2 Neurology

1.8.4.3 Oncology

1.8.4.4 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE 2.1 Regional Market Overview

2.1.1 The United States

2.1.1.1 Market Overview by Biomarker Technology

2.1.1.2 Market Overview by Biomarker Therapeutic Area

2.1.1.3 Major Market Players

Abbott Laboratories

Affymetrix, Inc

Agilent Technologies

AltheaDx

Amgen

Analytical Biological Services Inc.

Applied NeuroSolutions

Asuragen, Inc

Aureon Biosciences

AVIVA Biosciences Corporation

Banyan Biomarkers Inc.

Beckman Coulter, Inc

Becton, Dickinson and Company

BG Medicine Inc.

Biomarker Pharmaceuticals, Inc.

Bio-Rad Laboratories

Bristol-Myers Squibb Company

Celera Corporation

Charles River Laboratories International, Inc

Clarient, Inc

Eli Lilly and Company

Gene Logic, Inc.

GeneGo

Genentech, Inc

Genomic Health Inc

Geron Corporation

HistoRx, Inc.

Life Technologies

Merck & Co., Inc.

Millennium Pharmaceuticals, Inc.

Millipore Corporation

Monogram Biosciences, Inc.

Myriad Genetics, Inc

OSI Pharmaceuticals

Pacific Biomarkers, Inc

PerkinElmer, Inc.

Pfizer, Inc.

Philips Healthcare

Roche Diagnostics Corporation

Shimadzu Scientific Instruments, Inc.

Siemens Healthcare Diagnostics Inc.

Sigma-Aldrich Corporation

Thermo Fisher Scientific, Inc

2.1.2 Europe

2.1.2.1 Market Overview by European Region

2.1.2.2 Market Overview by Biomarker Technology

2.1.2.3 Market Overview by Biomarker Therapeutic Area

2.1.2.4 Biomarker Technology Market Overview by European Region

Bioinformatics

Genomics

Molecular Imaging

Proteomics

Other Biomarker Discovery Technologies

2.1.2.5 Major Market Players

ACE BioSciences A/S (Denmark)

Affibody AB (Sweden)

Agendia B.V (Netherlands)

Alphalyse A/S (Denmark)

AstraZeneca plc (United Kingdom)

Bayer AG (Germany)

Biacore International AB (Sweden)

Biocartis (Switzerland)

bioMerieux SA (France)

Biosystems International (France)

Boehringer Ingelheim (Germany)

Dako A/S (Denmark)

deCODE Genetics (Iceland)

Epigenomics AG (Germany)

Genedata AG (Switzerland)

GE Healthcare (United Kingdom)

GlaxoSmithKline (United Kingdom)

Novartis AG (Switzerland)

Sanofi-Aventis (France)

2.1.2.6 European Market Overview by Country

Germany

The United Kingdom

France

Italy

Spain

Sweden

Rest of Europe

2.1.3 Asia-Pacific

2.1.3.1 Market Overview by Asia-Pacific Region

2.1.3.2 Market Overview by Biomarker Technology

2.1.3.3 Market Overview by Biomarker Therapeutic Area

2.1.3.4 Biomarker Technology Market Overview by Asia-Pacific Region

Bioinformatics

Genomics

Molecular Imaging

Proteomics

Other Biomarker Discovery Technologies

2.1.3.5 Major Market Players

Astellas Pharma (Japan)

GVK Biosciences Private Ltd (India)

Human Metabolome Technologies Inc. (Japan)

Takeda Pharmaceutical Company Limited (Japan)

2.1.3.6 Asia-Pacific Market Overview by Country

Japan

China

India

Australia

Rest of Asia-Pacific

2.1.4 Rest of World

2.1.4.1 Market Overview by Biomarker Technology

2.1.4.2 Market Overview by Biomarker Therapeutic Area

2.1.4.3 Major Market Players

Ambrilia Biopharma Inc (Canada)

Compugen Ltd. (Israel)

3. GUIDE TO THE INDUSTRY

3.1 North America

3.1.1 Canada

3.1.2 United States

3.2 Europe

3.2.1 Belgium

3.2.2 Denmark

3.2.3 Finland

3.2.4 France

3.2.5 Germany

3.2.6 Iceland

3.2.7 Norway

3.2.8 Spain

3.2.9 Sweden

3.2.10 Switzerland

3.2.11 The Netherlands

3.2.12 United Kingdom

3.3 Asia-Pacific

3.3.1 Australia

3.3.2 China

3.3.3 India

3.3.4 Japan

3.4 Rest of World

3.4.1 Israel

4. ANNEXURE 4.1 Research methodology

4.2 The Questionnaire

4.3 Feedback </

Charts & GraphsGLOBAL MARKET PERSPECTIVE

Chart 1: Primary Areas of Guidance in Considering Molecular Imaging as a Cancer Biomarker

Chart 2: The Classes of Biomarkers as Defined by FDA Pharmacogenomics Guidelines

Chart 3: Global Biomarkers Market Analysis (2007-2015) in USD Million

Chart 4: Global Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Molecular Imaging, Proteomics and Other in USD Million

Chart 5: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Molecular Imaging, Proteomics and Other

Chart 6: Global Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million

Chart 7: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other

Chart 8: Global Bioinformatics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 9: Glance at 2007, 2010 and 2015 Global Bioinformatics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 10: Global Genomics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 11: Glance at 2007, 2010 and 2015 Global Genomics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 12: Global Molecular Imaging Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 13: Glance at 2007, 2010 and 2015 Global Molecular Imaging Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 14: Global Proteomics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 15: Glance at 2007, 2010 and 2015 Global Proteomics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 16: Global Other Biomarker Discovery Technologies Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 17: Glance at 2007, 2010 and 2015 Global Other Biomarker Discovery Technologies Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 18: Global Biomarkers Market Analysis (2007-2015) in Cardiology by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 19: Glance at 2007, 2010 and 2015 Global Cardiology Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 20: Global Biomarkers Market Analysis (2007-2015) in Neurology by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 21: Glance at 2007, 2010 and 2015 Global Neurology Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 22: Global Biomarkers Market Analysis (2007-2015) in Oncology by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 23: Glance at 2007, 2010 and 2015 Global Oncology Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

Chart 24: Global Biomarkers Market Analysis (2007-2015) in Other Disease Areas by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 25: Glance at 2007, 2010 and 2015 Global Other Disease Areas Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET PERSPECTIVE

Chart 26: The Projection of Largest Regions in terms of Market Growth for Biomarkers by Geography – Asia-Pacific, Europe, United States and Rest of World

Chart 27: Global Biomarkers Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 28: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

The United States

Chart 29: United States Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 30: Glance at 2007, 2010 and 2015 United States Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Chart 31: United States Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million

Chart 32: Glance at 2007, 2010 and 2015 United States Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other

EUROPE

Chart 33: European Biomarkers Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million

Chart 34: Glance at 2007, 2010 and 2015 European Biomarkers Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe

Chart 35: European Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 36: Glance at 2007, 2010 and 2015 European Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Chart 37: European Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million

Chart 38: Glance at 2007, 2010 and 2015 European Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other

Chart 39: European Bioinformatics Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million

Chart 40: Glance at 2007, 2010 and 2015 European Bioinformatics Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe

Chart 41: European Genomics Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million

Chart 42: Glance at 2007, 2010 and 2015 European Genomics Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe

Chart 43: European Imaging Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million

Chart 44: Glance at 2007, 2010 and 2015 European Imaging Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe

Chart 45: European Proteomics Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million

Chart 46: Glance at 2007, 2010 and 2015 European Proteomics Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe

Chart 47: European Other Biomarker Discovery Technologies Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million

Chart 48: Glance at 2007, 2010 and 2015 European Other Biomarker Discovery Technologies Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe

Germany

Chart 49: German Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 50: Glance at 2007, 2010 and 2015 German Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

The United Kingdom

Chart 51: United Kingdom Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 52: Glance at 2007, 2010 and 2015 United Kingdom Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

French

Chart 53: French Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 54: Glance at 2007, 2010 and 2015 French Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Italian

Chart 55: Italian Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 56: Glance at 2007, 2010 and 2015 Italian Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Spanish

Chart 57: Spanish Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 58: Glance at 2007, 2010 and 2015 Spanish Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Sweden

Chart 59: Swedish Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 60: Glance at 2007, 2010 and 2015 Swedish Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Rest of Europe

Chart 61: Rest of Europe Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 62: Glance at 2007, 2010 and 2015 Rest of Europe Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

ASIA-PACIFIC

Chart 63: Asia-Pacific Biomarkers Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million

Chart 64: Glance at 2007, 2010 and 2015 Asia-Pacific Biomarkers Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World

Chart 65: Asia-Pacific Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 66: Glance at 2007, 2010 and 2015 Asia-Pacific Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Chart 67: Asia-Pacific Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million

Chart 68: Glance at 2007, 2010 and 2015 Asia-Pacific Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other

Chart 69: Asia-Pacific Bioinformatics Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million

Chart 70: Glance at 2007, 2010 and 2015 Asia-Pacific Bioinformatics Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World

Chart 71: Asia-Pacific Genomics Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million

Chart 72: Glance at 2007, 2010 and 2015 Asia-Pacific Genomics Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World

Chart 73: Asia-Pacific Imaging Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million

Chart 74: Glance at 2007, 2010 and 2015 Asia-Pacific Imaging Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World

Chart 75: Asia-Pacific Proteomics Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million

Chart 76: Glance at 2007, 2010 and 2015 Asia-Pacific Proteomics Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World

Chart 77: Asia-Pacific Other Biomarker Discovery Technologies Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million

Chart 78: Glance at 2007, 2010 and 2015 Asia-Pacific Other Biomarker Discovery Technologies Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World

Japan

Chart 79: Japanese Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 80: Glance at 2007, 2010 and 2015 Japanese Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

China

Chart 81: Chinese Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 82: Glance at 2007, 2010 and 2015 Chinese Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

India

Chart 83: Indian Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 84: Glance at 2007, 2010 and 2015 Indian Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Australia

Chart 85: Australian Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 86: Glance at 2007, 2010 and 2015 Australian Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Rest of Asia-Pacific

Chart 87: Rest of Asia-Pacific Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 88: Glance at 2007, 2010 and 2015 Rest of Asia-Pacific Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

REST OF WORLD

Chart 89: Rest of World Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million

Chart 90: Glance at 2007, 2010 and 2015 Rest of World Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Chart 91: Rest of World Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million

Chart 92: Glance at 2007, 2010 and 2015 Rest of World Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other

To order this report:Biotechnology Industry: Biomarkers: Discovery Techniques and Applications – A Global Market Overview

Biotechnology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Reportlinker Adds Proteomics - Technologies, Markets and Companies
2. Reportlinker Adds Biotechnology Pharmaceutical Market in US -2013
3. Reportlinker Adds US Vaccines Market
4. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
5. Reportlinker Adds Womens Infertility - Pipeline Assessment and Market Forecasts to 2017
6. Reportlinker Adds Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
7. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
8. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
9. Reportlinker Adds Protein Kinase Therapeutics in Oncology - Where to Commercialize?
10. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
11. Reportlinker Adds Advances in Biopharmaceutical Technology in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , February 5, 2016 ... a biotechnology company focused on developing products for Regenerative ... requested Rare Pediatric Disease Designation (RPDD) from the US ... (RP) with MANF. MANF was previously granted orphan drug ... --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... New FDA action date of July 22, ... July 22, 2016   --> - ... - Lifitegrast has the potential to be the only ... signs and symptoms of dry eye disease in adults --> ... approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... Falls Church, VA (PRWEB) , ... ... ... a first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes ... Bloomsburg, PA. The two-day event features 20+ speakers and activities such as ...
(Date:2/4/2016)... British Columbia and MENLO PARK, Calif. ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... today announced that it will present at the 18 ... Monday, February 8, 2016 at 10:00 a.m. EST in ... Bacha , DelMar,s president and CEO, will provide an update ...
Breaking Biology Technology:
(Date:2/1/2016)... 1, 2016 Rising sales of ... global touchfree intuitive gesture control market size ... sales of consumer electronics coupled with new technological advancements ... size through 2020   --> ... new technological advancements to drive global touchfree intuitive gesture ...
(Date:1/27/2016)... Ohio , Jan. 27, 2016  Rite Track, ... based in West Chester, Ohio ... award winning service staff, based in Austin, ... capacity and ability to provide modifications, installations and technical ... Dovalina , CEO of PLUS, commented, "PLUS has provided ...
(Date:1/22/2016)... DUBLIN , Jan. 22, 2016 /PRNewswire/ ... announced the addition of the "Global ... report to their offering. --> ... of the "Global Biometrics Market in ... offering. --> Research and ...
Breaking Biology News(10 mins):